Month: March 2024

Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer’s therapeutics

Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated […]

Published on March 28, 2024

Spatial-temporal parameters during unobstructed walking in people with Parkinson’s disease and healthy older people: a public data set

Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated […]

Published on March 28, 2024

Aphantasia and hyperphantasia: exploring imagery vividness extremes

The vividness of imagery varies between individuals. However, the existence of people in whom conscious, wakeful imagery is markedly reduced, or absent entirely, was neglected by psychology until the recent coinage of ‘aphantasia’ to describe this phenomenon. ‘Hyperphantasia’ denotes the converse – imagery whose vividness rivals perceptual experience. Around 1% and 3% of the population […]

Published on March 28, 2024